share_log

16 Analysts Have This To Say About Globus Medical

16 Analysts Have This To Say About Globus Medical

16位分析師對Globus Medical的看法
Benzinga ·  12/19 05:00
In the preceding three months, 16 analysts have released ratings for Globus Medical (NYSE:GMED), presenting a wide array of perspectives from bullish to bearish.
在之前的三個月中,16位分析師對Globus Medical(紐交所:GMED)發佈了評級,展現了從看好到看淡的各種觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下面的表格提供了他們最近評級的快照,展示了過去30天情緒的變化,並與前幾個月進行了比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $91.31, a high estimate of $115.00, and a low estimate of $78.00. Surpassing the previous average price target of $81.81, the current average has increased by 11.61%.
分析師評估的12個月價格目標揭示了進一步的見解,平均目標爲91.31美元,最高預估爲115.00美元,最低預估爲78.00美元。當前的平均價格目標已超過之前的平均價格目標81.81美元,增加了11.61%。
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查:一項詳盡的研究
The analysis of recent analyst actions sheds...
近期分析師行動...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論